A client is prescribed bethanechol (Urecholine) 10 mg PO tid. ...

[justinmsk]

A client is prescribed bethanechol (Urecholine) 10 mg PO tid. What will the nurse determine as an adverse effect of this medication?
 
  1. Nausea and vomiting
  2. Blurred vision
  3. Orthostatic hypotension
  4. Increased peristalsis
  5. Slow respiratory rate

Question 2

A client is prescribed donepezil (Aricept) for treatment of Alzheimer disease. What will the nurse instruct the client about this medication?
 
  Standard Text: Select all that apply.
  1. This medication will improve memory.
  2. This medication will improve thinking.
  3. This medication slows the progression of the disease.
  4. This medication will cure the disease.
  5. This medication causes a long-term improvement in the progression of the disease.

[vickyvicksss]

Answer to Question 1

Correct Answer: 1,2,3
Rationale 1: Nausea and vomiting are an adverse effect of a direct cholinergic agonist such as bethanechol.
Rationale 2: Blurred vision is an adverse effect of a direct cholinergic agonist such as bethanechol.
Rationale 3: Orthostatic hypotension is an adverse effect of a direct cholinergic agonist such as bethanechol.
Rationale 4: Increased peristalsis is an expected effect of a direct cholinergic agonist such as bethanechol.
Rationale 5: A slow respiratory rate is an expected effect of a direct cholinergic agonist such as bethanechol.
Global Rationale: Nausea and vomiting, blurred vision, and orthostatic hypotension are adverse effect of a direct cholinergic agonist such as bethanechol. Increased peristalsis and a slow respiratory rate are both expected effects of a direct cholinergic agonist such as bethanechol.

Answer to Question 2

Correct Answer: 1,2
Rationale 1: This medication increases the amount of acetylcholine in cholinergic synapses in the brain, which improves memory.
Rationale 2: This medication increases the amount of acetylcholine in cholinergic synapses in the brain, which improves cognitive functioning.
Rationale 3: Acetylcholinesteras e inhibitors do not slow the progression of Alzheimer disease.
Rationale 4: Acetylcholinesteras e inhibitors do not cure Alzheimer disease.
Rationale 5: Acetylcholinesteras e inhibitors do not cause a long-term improvement in the progression of Alzheimer disease. Improvement is limited and short-lived.
Global Rationale: This medication increases the amount of acetylcholine in cholinergic synapses in the brain, which improves memory and cognitive functioning. Acetylcholinesteras e inhibitors do not slow the progression of Alzheimer disease or cure it. Acetylcholinesteras e inhibitors do not cause a long-term improvement in the progression of Alzheimer disease. Improvement is limited and short-lived.

[justinmsk]

TY

[vickyvicksss]

You're welcome